Verinurad is a selective URAT1 inhibitor developed for gout and heart failure by AstraZeneca. Johansson, Susanne; Han, David; Hunt, Thomas; Björck, Karin;...
4 KB (194 words) - 21:41, 31 December 2023
have a protein-protein interaction with PDZK1. Lesinurad, Ruzinurad, Verinurad, Epaminurad, Lingdolinurad, Xininurad, Puliginurad and dotinurad are urate...
9 KB (1,079 words) - 11:05, 18 July 2024